Applied Genetic Technologies Corporation Appoints David R. Guyer, MD, And Ivana Magovcevic-Liebisch, Phd, JD, To Its Board Of Directors
6/30/2014 7:53:32 AM
GAINESVILLE, Fla., June 30, 2014 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today announced that it has appointed David R. Guyer, MD, and Ivana Magovcevic-Liebisch, PhD, JD, to the company's Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by